Revenue Halved, But the Real Collapse is Elsewhere
A ₹532 crore revenue delay explains Q1's 63% headline miss. But the quarter still reveals margin slippage, back-loaded presales, and a Senior Living thesis not yet proven at scale — the market's 6% sell-off looks fair.
The OC timing shock (and what really happened)
Revenue ₹107 crore in Q1 FY27 looks like a catastrophe — 63% down from ₹293 crore a year ago. But the call reveals why: Ashiana Anmol Phase 3 and Amarah Phase 1 received occupancy certificates mid-July, after the quarter closed. That postponed ₹532 crore in revenue recognition to Q2. Strip it out, and the organic picture is: Q1 presales (₹358 Cr) and collections (₹409 Cr) tracked planned, but delivery timing outside management's control turned the quarter optics upside down. Management was explicit on this: quarterly revenues for real estate are inherently lumpy and unpredictable.
₹107 Cr
-63% YoY
₹532 Cr
Anmol Phase 3 + Amarah Phase 1
₹121 Cr
+12% YoY
The cash story is cleaner: collections hit ₹409 crore (+6% YoY), operating cash flow rose to ₹121 crore, and customer payment discipline remained intact. The tax rate (22.4%) was normal. Ashiana pulled forward nothing and punted no real problems; it was a logistics miss, not a demand one.
Management's claims vs. what holds up
Collections robust at ₹409 Cr, +6% YoY
₹409 Cr confirmed; OCF also up 12% YoY to ₹121 Cr
Supported
Average realization +37% YoY to ₹9,923/sqft
Achieved via mix shift (fewer, larger units: 234 vs 407) and premiumization into Senior Living segment
Supported
On track for ₹2,200 Cr FY27 presales guidance
₹859 Cr by July 31 (YTD); needs ₹1,050–1,100 Cr in H1 and ₹1,100–1,150 Cr in H2. Critically back-loaded
Overstated (execution-dependent)
Current project margins mid-20s gross; target 30%
Anmol Phase 3 & Amarah Phase 1 blended mid-20s (both Phase 1s, lower). Management says later phases will improve but offers no detail on timing
Contradicted (gap real; path unclear)
Senior Living ₹570 Cr presales FY26; targeting ₹1,500 Cr FY29-30 (25% CAGR)
₹570 Cr confirmed. CAGR at low base is plausible math but unproven at scale. Vadgaon 20L sqft, ₹1,800 Cr sales value is largest ever; absorption rates and pricing power untested
Supported (structurally credible; operationally unproven)
What changed from prior guidance
Presales pace moderated Q1 (₹358 Cr well below monthly run-rate)
FY27 presales guidance maintained (₹2,200 Cr, no raise despite July momentum)
Senior Living acceleration: Vadgaon Pune 28.55 acres, ₹1,800 Cr potential — largest deal ever for the segment
Project margin target of 30% gross shown as reach — current deliveries mid-20s, risk to PAT guidance (12–13% at project level)
Management willing to accept 1–2 year presales dip as capital shifts to Senior Living; medium-term presales target ₹3,000–4,000 Cr (vs ₹2,200 Cr now)
The bull-bear ledger
Collections and cash flow remain disciplined (+6% and +12% YoY); no working capital stress
Premiumization evident (+37% average realization); brand pricing power intact
Senior Living structural tailwind real (aging population, urbanization, first-mover positioning); Vadgaon deal sizes ambition
Revenue down 63% YoY on timing, but Q2 will see ₹532 Cr shift — perception damage already done
Margin gap between aspiration (30%) and current delivery (mid-20s); Phase 1 lower margin excuse needs follow-through proof in Phase 3+
Presales guidance maintained but requires ₹1,100+ Cr in H2; back-loaded execution is concentration risk (Aaroham Phase 3 critical)
Senior Living scale-up to ₹1,500 Cr presales by FY29-30 depends on demand, pricing, and absorption rates all unproven at this volume
Inventory constraints in Gurugram, Jaipur, Bhiwadi acknowledged; near-term presales growth sacrificed for capital reallocation
Risks, ranked by holder concern
1. H2 presales execution collapse
HighFY27 ₹2,200 Cr guidance needs ₹1,100+ Cr presales in H2. Aaroham Phase 3 (Q3/Q4) is critical. Delays push guidance miss; investors punish top-line misses regardless of margin story.
2. Project margin gap vs. target
HighCurrent deliveries mid-20s vs 30% aspiration. If Phase 3+ also underperform or pricing power weakens, PAT guidance (12–13% at project level) is at risk. Margin thesis is unproven.
3. Senior Living scale-up risk
High₹1,500 Cr presales target by FY29-30 (25% CAGR) is ambitious from ₹570 Cr base. Vadgaon 20L sqft, ₹1,800 Cr sales value on 10-year timeline assumes 2L sqft/year absorption and pricing discipline. Demand, mix, and speed all unproven at this scale.
4. Inventory constraints limiting growth
MediumDeliberate capital pivot to Senior Living caps presales 1–2 years. Investors typically penalize absent top-line growth, even if strategic rationale is sound.
5. Bengaluru South Kanakapura Road (CP resolution pending)
MediumPilot market for expansion delayed; 'sooner or later' is vague. Regulatory timelines outside management control; slippage ripples into H2 presales.
6. IFC co-investment platform exhaustion
LowLoss of institutional co-investor for future deals; may constrain capital for new markets and scaling initiatives.
How the street is positioned
The post-result price action tells a story: down 2.08% on day 1, fading to −5.86% by day 3 and holding there. The initial move didn't bounce back — a damning market verdict. The stock has since drifted lower, now trading at ₹365.2, which is 16.22% off its all-time high (₹435.9) but still 35.54% above its 52-week low. It sits below both SMA20 (₹381.44) and SMA50 (₹378.99), below key technical support, but above SMA200 (₹329.09), suggesting short-term momentum is broken.
Ownership is stable but flat: FII ownership ticked down 10 basis points QoQ to 8.18% (vs DII flat at 8.08%, promoter steady at 61.11%). The tick is small, but institutions are not rushing in on the weakness. Volume trend is decreasing, a warning sign that the stock is losing momentum from both retail and institutional flows. RSI at 32.7 is neutral — no capitulation, no euphoria.
This alignment matters: my fundamental read (decent execution offset by margin pressure and back-loaded execution risk, Senior Living unproven) matches the market's verdict. The stock is repricing Ashiana from a "growth story" (pre-ATH ₹435.9) into a "show-me story" (now ₹365.2). That repricing is not overblown.
The debate
The bull case: Senior Living is a demographic certainty (aging population, family structure change, urbanization). Ashiana is a first-mover with brand equity and financial discipline. Presales are tracking (₹859 Cr YTD, on pace for ₹2,200 Cr) and collections are solid. The ₹532 Cr OC timing is a one-off; annual revenue ₹2,000 Cr guidance is the real metric, not quarterly noise. At 15% ROE floor with Senior Living upside, the stock trades at a reasonable multiple for a disciplined builder.
The bear case: Revenue down 63% YoY is a headline that sticks, no matter the OC excuse. Presales are back-loaded into H2, concentrating execution risk into Aaroham Phase 3 launch. Margin guidance (30% gross) is a fantasy — current delivery is mid-20s with no clear path to 30%. Senior Living scale-up to ₹1,500 Cr is a multi-year bet on unproven demand at scale. Inventory constraints mean 1–2 years of presales stagnation. ROE guidance walked back from 20% to 15%. Institutions are selling, not buying.
The honest read: This is a decent operator executing a structural pivot, but execution is soft, margins are under pressure, and the Senior Living bet is real but unproven. Management is candid (credible) but hedged (cautious tone). The stock repricing from ₹435.9 to ₹365.2 reflects this: from "growth story" to "show-me story." Not a turnaround play; not a broken value trap. A mid-tier real estate franchise retooling for a new market with good demographics and structural tailwinds — but no moat yet, and the near term is execution-dependent.
What to watch next
1 · Q2 FY27 presales and delivery momentum (next results, expected ~October)
The ₹532 Cr OC shift to Q2 revenue will show up in the P&L. Watch for presales run-rate ex-July (i.e., Aug–Sep): are launches delivering ₹250+ Cr/month or fading? Aaroham Phase 3 announcement timing matters hugely. If presales cool after July's pop, guidance risk rises.
2 · Project margin trajectory (FY27 mid-year and full-year updates)
Management must prove Phase 3+ margins exceed Phase 1 (mid-20s). Gross margin of 25%+ and operating leverage (12% SG&A) are required for the 18% PBT / 12–13% PAT story to hold. If H1 FY27 deliveries stay mid-20s gross, the 30% target is vapor.
3 · Senior Living absorption and pricing (Vadgaon launch ~H2 FY28, first pre-sales by FY28-end)
The structural case for Senior Living is real, but scale is untested. Vadgaon pre-sales metrics (units, price per sqft, presales velocity) will validate the ₹1,500 Cr FY29-30 thesis or expose absorption/pricing risk. This is the multi-year story. Single miss doesn't kill it; two misses in a row do.
Ashiana Housing is executing a smart, structural pivot toward Senior Living — a demographic tailwind and less cyclical than residential. But this quarter proved that near-term visibility is weak: OC timing made Q1 optics terrible (revenue down 63%), presales are back-loaded into H2 with execution concentration risk, margins are being compressed (mid-20s vs 30%), and the Senior Living scale thesis is still a thesis, not a fact.
The market's 6% sell-off is fair. This is not a brokerage recommendation; it is a "wait and see" on both presales execution and margin trajectory. Steady execution over the next two quarters — Aaroham ramping, Bengaluru unblocked, presales run-rate sustained, and evidence of margin improvement — could rebuild confidence. For now, the stock is repricing downside to reflect that wait.
The single number to track from here: Presales momentum in H2 (target ₹1,100+ Cr). If management hits it, the FY27 guidance is safe and the Senior Living bet gains credibility. If H2 stumbles, the back-loading story breaks, and downside re-risks the entire thesis.
Informational and educational content only. Not investment advice.